Taiwan TFDA Medical Device Registration Guide (2026): Complete Process, Fees, Timeline & Requirements

Overview of Taiwan's Medical Device Market

Taiwan is one of the most dynamic medical device markets in the Asia-Pacific region. With a market valued at approximately $3.2 billion (growing at a CAGR of 5.59%) and an IVD market of approximately $1.39 billion (CAGR of 8.4%), Taiwan offers significant opportunities for international device manufacturers. The market is driven by advanced healthcare infrastructure, rising healthcare spending (6.4% of GDP), and a rapidly aging population (17.56% aged 65+ in 2021, projected to reach 20% by 2025).

Taiwan modernized its medical device regulatory framework in May 2021 with the passage of the Medical Devices Act, which replaced the older Pharmaceutical Affairs Act provisions governing medical devices. The new Act brought clearer classification rules, updated registration procedures, mandatory UDI requirements, and reinforced post-market surveillance.

The regulatory authority is the Taiwan Food and Drug Administration (TFDA), a division of the Ministry of Health and Welfare (MOHW). The Division of Medical Devices and Cosmetics within the TFDA administers medical device regulations.

Regulatory Framework

Key Legislation

Regulation	Effective Date	Purpose
Medical Devices Act (2021)	May 1, 2021	Primary framework for medical device regulation, replacing older Pharmaceutical Affairs Act provisions
Regulations Governing the Classification of Medical Devices	August 22, 2023	Defines classification rules and categories
Regulations Governing Issuance of Medical Device License, Listing and Annual Declaration	November 27, 2023	License issuance, listing, and annual reporting requirements
Regulations for Medical Device Recalls	May 1, 2021	Recall procedures and requirements
Regulations for Management of Medical Device Safety Surveillance	May 1, 2021	Vigilance and post-market safety surveillance
Regulations Governing Border Inspection and Examination of Imported Medical Devices	March 31, 2025	Import inspection procedures
Guidance for Industry on Management of Cybersecurity in Medical Devices	May 5, 2021	Cybersecurity requirements

Regulatory Authority

TFDA (Taiwan Food and Drug Administration) under the Ministry of Health and Welfare (MOHW) is responsible for:

• Medical device classification and registration
• Quality System Documentation (QSD) certification
• Pre-market approval for all device classes
• Post-market surveillance and vigilance
• Recall management
• UDI database management
• Border inspection of imported devices

Device Classification

Taiwan uses a three-tier, risk-based classification system for medical devices and IVDs:

Class	Risk Level	Review Pathway	Examples
Class I	Low risk	Administrative review (listing or registration)	Non-sterile bandages, manual surgical instruments, examination gloves
Class II	Moderate risk	Administrative + technical review	Blood pressure monitors, surgical lasers, dental implants
Class III	High risk	Full technical review with clinical data	Heart valves, pacemakers, implantable neurostimulators

Classification Categories

Taiwan assigns devices a classification code consisting of a letter (A–P) plus 4 digits, corresponding to 16 functional categories:

Code	Category	Code	Category
A	Clinical chemistry and clinical toxicology	I	Cardiovascular devices
B	Hematology, pathology, and genetics	J	Dental devices
C	Immunology and microbiology	K	Ear, nose, and throat devices
D	Anesthesiology devices	L	Gastroenterology and urology devices
E	General hospital and personal use	M	General and plastic surgery devices
F	General and plastic surgery devices	N	Neurology devices
G	Obstetrical and gynecological devices	O	Ophthalmic devices
H	Orthopedic devices	P	Physical medicine devices

Classification can be determined by querying the TFDA's device classification database.

Quality System Documentation (QSD)

What Is QSD?

Before a medical device can be sold in Taiwan, the manufacturing facility must obtain a Quality System Documentation (QSD) certificate from the TFDA. QSD is Taiwan's equivalent of Good Manufacturing Practice (GMP) for medical devices. It certifies that the manufacturer's quality management system meets Taiwan's regulatory standards.

QSD Requirements by Device Class

Device Class	QSD Required?
Class I (non-sterile, non-measuring)	No — exempt from QSD
Class I (sterile or measuring)	Yes
Class II	Yes
Class III	Yes
New devices (no predicate)	Yes

QSD Application Modes

Mode	Who Can Use	Documentation Required
Standard	All manufacturers	Full QSD documentation (ISO 13485, facility layout, equipment lists, manufacturing and QC procedures)
Essential	Manufacturers of certain designated product categories	Simplified documentation
US Abbreviated	Manufacturers located in the US	Leverages US FDA audit reports and QS compliance evidence
TCP Abbreviated (Technical Cooperation Program III)	Manufacturers certified by EU Notified Bodies compliant with EU MDR 2017/745 and IVDR 2017/746	Leverages EU conformity assessment

The TCP III Abbreviated Mode is particularly advantageous for EU-based manufacturers — it allows expedited QSD review by leveraging ISO 13485 certification from one of the 6 TFDA-approved TCP III Notified Bodies.

QSD Fees and Timeline

Application	TFDA Fee	TFDA Turnaround Time
QSD Standard	NT$60,000 (~US$2,000)	120 calendar days
QSD Essential	NT$30,000 (~US$1,000)	Shorter

For foreign manufacturers, QSD review is document-based (no on-site inspection). For local manufacturers, TFDA-authorized auditing organizations perform on-site inspections.

Local Agent / Taiwan Agent Requirement

Who Needs a Local Agent?

All foreign manufacturers must appoint a Taiwan Agent (also called Local Legal Representative) to manage device registration and interact with the TFDA on their behalf. The Taiwan Agent must:

• Be a company established in Taiwan
• Hold a valid business license and medical device business permit
• Be registered to conduct medical device activities

Taiwan Agent Responsibilities

• Submit registration applications to the TFDA
• Manage QSD certification process
• Act as primary regulatory liaison with TFDA
• Handle Serious Adverse Event (SAE) reporting
• Maintain QSD license and device registration
• Hold the TFDA-approved Medical Device Product License (in most cases)
• Manage license transfers and renewals
• Oversee post-market activities including recalls

Registration Process

Prerequisites

Before applying for registration:

1. Determine your device's classification using the TFDA classification database
2. Identify if a predicate device exists in Taiwan (similar previously approved device)
3. Obtain home country approval (required for Class II and III devices)
4. Prepare QSD documentation (if applicable)
5. Appoint a Taiwan Agent

Step-by-Step Registration

Step 1 — Classify Your Device

Query the TFDA device classification database to determine your device class and classification code. Classification determines the documentation requirements, review pathway, and fees.

Step 2 — Identify a Predicate Device

Search the TFDA's public database for similar approved devices. If a predicate exists, the registration process is simpler. If no predicate exists, your device is classified as a "new device" (PMA) and undergoes the most rigorous review.

Important: Even if your device has an FDA Substantially Equivalent (SE) device in the US, it may still be classified as "new" in Taiwan if no TFDA-approved predicate exists.

Helpful note: As long as your product is registered in its country of origin and you can provide a valid Free Sale Certificate, it can be registered in Taiwan. Reference country approvals (beyond the home country) are not strictly required, though they strengthen your application. TFDA published the "Determination Process of Similar Products of Medical Devices and Instructions for Application by Letter of Inquiry" guidelines in May 2021 to help manufacturers identify predicates.

Step 3 — Appoint a Taiwan Agent

Engage a local agent or regulatory services firm to represent you before the TFDA.

Step 4 — Submit QSD Application

For Class I (sterile/measuring), Class II, and Class III devices, submit the QSD application to the TFDA. QSD review may run concurrently with the product registration review.

Step 5 — Prepare Registration Dossier

Compile the required documentation for your device class.

Common Documents for All Classes:

• Free Sales Certificate (FSC) — notarized true copy, issued within the past 2 years (notarization waived for US, Canada, and Australia manufacturers)
• Authorization letter from manufacturer to Taiwan Agent
• Device specifications and design descriptions
• Labeling and IFU (Traditional Chinese)
• Clinical evaluation data

Additional Documents for Class II and III:

• Technical dossier with test reports
• Clinical data (may include literature review, clinical investigation reports)
• Risk analysis
• Biocompatibility data (if applicable)
• Software documentation (if applicable)

Step 6 — Submit Application to TFDA

The Taiwan Agent submits the application and pays the applicable fee. TFDA reviews the application and may request additional information.

Step 7 — TFDA Review

Device Class	Review Type	TFDA Fee	TFDA Review Time
Class I (Listing)	Administrative only	NT$10,000 (~US$333)	Not officially announced (est. 60–80 days)
Class I (Registration)	Administrative review	NT$15,000 (~US$500)	80 calendar days
Class II (with predicate)	Administrative + Technical	NT$58,000–60,000 (~US$1,900–2,000)	140 calendar days
Class III (with predicate)	Full technical review	NT$100,000 (~US$3,333)	200 calendar days
New device (no predicate)	Full review + expert consultation	NT$130,000 (~US$4,333)	220 calendar days

Review times exclude clock-stop periods for deficiency responses. Actual timelines including preparation and response time:

• Class I: 1–2 months
• Class I (sterile/measuring): 7–8 months (including QSD)
• Class II: 8–12 months
• Class III: 9–14 months
• New device: 10–15 months

Step 8 — License Issuance

Upon approval, TFDA issues a Medical Device Permit License. The license is valid for 5 years and must be renewed before expiry (renewal applications accepted within 6 months prior to expiration).

Licensing Fees Summary

Item	Fee (NT$)	Fee (US$ approx.)
QSD Standard	60,000	~2,000
QSD Essential	30,000	~1,000
Class I Listing	10,000	~333
Class I Registration	15,000	~500
Class II Registration	58,000–60,000	~1,900–2,000
Class III Registration	100,000	~3,333
New Device Registration	130,000	~4,333
License Certificate Copy	~50	~1.70

UDI Requirements

UDI implementation is mandatory in Taiwan under Article 33 of the Medical Devices Act:

Device Class	UDI Compliance Deadline
Class III	June 1, 2022
Class II	June 1, 2023
Class I	To be announced

License holders and listing applicants must:

• Upload UDI-related product information to the TFDA UDI Database (UDID)
• Place UDI on product labels (single unit package or directly marked on device)

Labeling and Language Requirements

All medical devices sold in Taiwan must have:

• Traditional Chinese labels affixed to the smallest packaging unit for sale
• Traditional Chinese Instructions for Use (IFU) provided

These requirements must be fulfilled before sale, wholesale, or retail. Exceptions may apply if specifically approved by the TFDA.

Post-Market Obligations

License Maintenance

• Product license valid for 5 years; renewal required
• For listing-eligible products: annual declaration/report due each October
• QSD certificate must be maintained

Vigilance and Safety Surveillance

• Serious Adverse Events (SAE) must be reported to the TFDA
• Field Safety Corrective Actions (FSCA) must be reported
• The Taiwan Agent manages vigilance activities on behalf of foreign manufacturers

Tracking Management System

For certain TFDA-designated medical devices, dealers must:

• Establish and maintain supply and distribution records
• Report records quarterly to ensure traceability

Change Management

After initial registration, significant product changes require a change registration before the modified product can be marketed in Taiwan. Typical significant changes include:

• Product name changes (Chinese or English)
• IFU, labeling, and packaging modifications
• Changes to product variants
• Performance enhancements
• Manufacturer name changes
• Production address changes
• Change of local representative

Common Challenges and How to Avoid Them

1. No TFDA-Approved Predicate

If your device is classified as "new," expect a longer and more expensive review. Conduct a thorough predicate search early. Consider whether your device can be positioned as similar to an existing TFDA-approved product.

2. Missing Home Country Approval

Class II and III devices must have approval from their country of origin before TFDA registration. A Free Sales Certificate is required. Obtain home country approval first.

3. QSD Delays

QSD review can take up to 120 calendar days. Apply for QSD early — it can run concurrently with product registration. EU and US manufacturers should use the abbreviated pathways.

4. Incorrect Classification

Taiwan's classification system, while risk-based, may differ from US or EU classifications. Verify your classification against the TFDA database and seek regulatory advice if uncertain.

5. Traditional Chinese Translation Issues

Poor translations of labels and IFU are a common cause of queries. Use qualified medical translators experienced in Traditional Chinese (not Simplified Chinese — Taiwan uses Traditional Chinese characters).

6. FSC Notarization Delays

FSC must be notarized within the past 2 years. Exception: notarization is waived for US, Canada, and Australia manufacturers. Plan ahead to avoid delays.

Total Cost Estimate

Cost Item	Estimated Range
TFDA registration fee (Class I)	~$333–500
TFDA registration fee (Class II)	~$1,900–2,000
TFDA registration fee (Class III)	~$3,333
TFDA registration fee (New device)	~$4,333
QSD application fee	~$1,000–2,000
Taiwan Agent fees (annual)	$5,000–$15,000
Regulatory consultant (dossier preparation)	$5,000–$25,000
Traditional Chinese translation (labels, IFU)	$2,000–$8,000
Clinical data preparation (if required)	$5,000–$30,000
Testing (if TFDA-specific testing required)	$5,000–$20,000
Total estimated cost per device	$18,000–$80,000

Key Takeaways

• All medical devices require TFDA pre-market approval — no exemptions by class
• The Medical Devices Act (2021) governs all device regulation in Taiwan
• Three classification tiers: Class I (low risk), Class II (moderate), Class III (high risk)
• QSD certification is mandatory for Class I sterile/measuring, Class II, and Class III devices
• Foreign manufacturers must appoint a Taiwan Agent — no exceptions
• Home country approval is required for Class II and III before TFDA registration
• UDI is mandatory for Class II and III devices (Class III since June 2022, Class II since June 2023)
• Traditional Chinese labeling and IFU required for all devices
• License valid for 5 years with renewal required
• Budget 1–15 months depending on device class and predicate availability
• Budget $18,000–$80,000 total per device including all costs
• EU and US manufacturers can use abbreviated QSD pathways to accelerate registration

2026 Regulatory Updates You Should Know

Border Inspection Regulations (March 2025)

Effective March 31, 2025, Taiwan updated its Regulations Governing Border Inspection and Examination of Imported Medical Devices. The updated regulations strengthen customs-level verification of medical device imports, requiring importers to demonstrate valid TFDA registration and license status at the border. Manufacturers should ensure their Taiwan Agents have current import documentation and that all device registrations are active.

TFDA E-Submission Development

TFDA is developing electronic submission systems for regulatory filings, replacing the previous hard-copy dossier requirements. The e-submission system will be rolled out in phases and will become mandatory in the near future. Manufacturers should prepare for a transition to digital submissions and monitor TFDA announcements for rollout dates.

AmCham Position Paper (June 2025)

The American Chamber of Commerce in Taiwan published its 2025 Medical Devices Position Paper highlighting key industry concerns:

• CFG/CFS requirements delay Taiwan registration timelines, as applicants must first obtain approval in their country of origin
• QSD interpretation inconsistencies between TFDA's Division of Quality Compliance and Management and the Division of Medical Devices and Cosmetics have led to misaligned approvals
• Reimbursement classification should not be based on "me-too" declarations used for regulatory approval — the NHIA should use clinically relevant device function distinctions
• Recommendations include streamlining CFS requirements to make Taiwan a priority launch destination

UDI Expansion

TFDA continues to expand UDI requirements. Class III devices have been required to comply since June 2022, and Class II since June 2023. Class I UDI requirements are expected to be announced in upcoming guidance. Manufacturers of Class I devices should prepare UDI implementation plans.

Cybersecurity Requirements

The TFDA's Guidance for Industry on Management of Cybersecurity in Medical Devices (published May 2021) is increasingly relevant as connected medical devices proliferate. Manufacturers of devices with network connectivity or data transmission capabilities should ensure their cybersecurity documentation meets TFDA expectations.

Frequently Asked Questions

How long does medical device registration take in Taiwan?

Class I listing: 1–2 months. Class I registration: 2–3 months. Class II (with predicate): 8–12 months. Class III (with predicate): 9–14 months. New device (no predicate): 10–15 months. Timelines include QSD processing.

Is a Free Sales Certificate required?

Yes. A notarized FSC issued within the past 2 years is required for Class II and III devices. Exception: notarization is waived for manufacturers from the US, Canada, and Australia.

Can I use my FDA 510(k) clearance as a predicate in Taiwan?

Not directly. Taiwan requires a TFDA-approved predicate — meaning a device already approved by the TFDA. Having an FDA SE device may help demonstrate similarity, but it does not guarantee Taiwan will classify your device as having a predicate.

Is ISO 13485 required?

ISO 13485 certification is required for QSD purposes for all devices except Class I non-sterile, non-measuring. The QSD application accepts ISO 13485 as evidence of quality system compliance.

Can my license be transferred to another agent?

Yes, license transfer is possible but requires documentation including transfer agreements, authorization letters, and the current license. The TFDA must approve the transfer.

Is local clinical data required?

Not always. Foreign clinical data is generally accepted. However, TFDA may request Taiwan-specific clinical data for certain high-risk devices or devices where population-specific factors are relevant.

Do I need local testing?

No specific local testing requirement exists. However, TFDA may request additional testing for certain device categories. Test reports from accredited international laboratories are generally accepted.

What happens after my 5-year license expires?

You must submit a renewal application within 6 months prior to expiration. The renewal process is generally simpler than initial registration, focusing on confirming continued compliance and any post-market data.